Chronic Lymphocytic Leukemia (CLL) is a B-lymphoproliferative disorder, characterized by the proliferation and accumulation of CD19/CD5-positive B cells in the peripheral blood, lymphatic organs, and bone marrow of patients [1]. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.